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Post-Conditioning for
ST-Segment Elevation
Myocardial Infarction
I read with interest the paper by Thuny et al. (1) published in the
June 12, 2012, issue of the Journal. The authors adequately
emonstrated the effectiveness of a post-conditioning strategy in
ecreasing the degree of myocardial edema as assessed by cardiac
agnetic resonance and hypothesized how this can be the result of
ecrease in infarct size.
Post-conditioning is, of course, in early stages of development,
nd clinical implications remain to be established as clearly pointed
ut by the authors; the findings of this randomized trial make
ost-conditioning a very promising strategy for the ongoing
mprovement of outcomes in the management of ST-segment
levation myocardial infarction. As such, I am interested to learn
hether the 26 patients not included in the analysis were evenly
istributed between control/intervention groups, because this in-
ormation can potentially affect the final interpretation of the
esults.
Figure 1 Study Enrollment and Randomization
Distribution of the excluded patients according to the treatment allocation. CMR 
Postcond  post-conditioning; TIMI  Thrombolysis In Myocardial Infarction.As post-conditioning transitions to becoming a clinically useful
management strategy for ST-segment elevation myocardial infarc-
tion, data with regard to the safety of the intervention should be
included in future research. Consequently, and given the potential
role this paper can play in the design of future larger phase 3
clinical trials, I would appreciate if the authors could provide
additional information on this issue.
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Reply
We thank Dr. Posada for his comments with regard to our recently
published report (1). In this study, we analyzed the effect of
post-conditioning on myocardial edema and infarct size. Patients
with previous myocardial infarction in the same territory, a
Thrombolysis In Myocardial Infarction flow grade 1, and evi-
dence of coronary collaterals to the area at risk were excluded, to
limit the influence of confounding factors. In Figure 1, we present
additional information with regard to the distribution of the excluded
patients according to the treatment allocation. Five control versus 7
post-conditioned patients were not included, due to absence or poor
ac magnetic resonance; MI  myocardial infarction;cardi
Rn
u
s
p
s
i
a
(
p
a
b
s
“
p
o
b
C
a
c
*
*
E
7
E
E
R
2342 Correspondence JACC Vol. 60, No. 22, 2012
December 4, 2012:2335–42cardiac magnetic resonance imaging. Therefore, it seems that there
was no imbalance in this distribution that might have biased the final
results.
As previously demonstrated by our team, mechanical post-
conditioning represents a feasible, safe, and efficient cardioprotec-
tive intervention (2). In this recent study, no adverse events
occurred in the post-conditioning group. It is, however, important
to stress that balloon deflation-reinflation as part of the post-
conditioning protocol must be performed (immediately) upstream
of the site of the culprit lesion (but not within the stent), to prevent
microembolization that might thwart the protection of post-
conditioning.
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Pre-Hypertension and
Hyperkinetic Heart (Gorlin’s)
Syndrome
Is There a Parallel?
The important study of Davis et al. (1), published in the June 12,
2012, issue of the Journal, delves into the genetic and hemody-
namic underpinnings of pre-hypertension (PH), a precursor of
established systemic hypertension with all the morbidity and
mortality connotations that are entailed. The cross-sectional twin
study of the authors identified a relationship of PH with hereditary
influences, rise of norepinephrine secretion, decline in parasympa-
thetic tone, elevation of cardiac contractility (maximal left ventric-
ular dP/dT), increased stroke volume, heart rate, cardiac output andpulse pressure, and failure of the systemic vascular resistance to decline
in the face of increased cardiac output, with resultant elevated blood
pressure at levels compatible with the definition of PH.
Over 50 years ago, Gorlin et al. (2–5) described the “hyperki-
etic heart syndrome,” a new clinical entity characterized by an
nexplained primary (as contrasted with all conceivable known
econdary causes) rise in stroke volume, cardiac output, pulse
ressure, and left ventricular ejection rate, mild systolic hyperten-
ion, positive cold pressor test, and increased oxygen consumption,
n a group of young, mainly asymptomatic subjects. The authors
ttributed the “hyperkinetic heart syndrome” to a “defect in central
neurohumoral) regulation of cardiac output” (4).
One would surmise, on the basis of the aforementioned, that
PH and “hyperkinetic heart syndrome” might have something in
common, if they do not represent the same pathophysiological
entity. Of note is that Gorlin et al. (5) remarked that “the high
revalence of all forms of hypertension, including systolic, labile,
nd sustained hypertension in these patients suggests a relationship
etween hypertension and hyperkinetic circulatory states,” with
ignificant support from the published data. Also they found a
benign short-term and 20-year prognosis in the majority of
atients with the idiopathic hyperkinetic heart syndrome” with
ccasions of regression, although they recommended beta-
lockade particularly for patients with hypertension (5). Because
Gorlin et al. found a high rate of “flow” murmurs on physical
examination of their subjects and electrocardiogram left ventricular
hypertrophy (2–5), it might be useful to evaluate the University of
alifornia, San Diego twin/family database (1), with regard to the
prevalence of these 2 items. Also in view of the follow-up study of
the “hyperkinetic heart syndrome” of Gorlin et al. (5), it might be
dvisable to have a follow-up study of PH in due time to
omplement the cross-sectional investigation by Davis et al. (1).
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